nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—VEGFA—head and neck cancer	0.584	1	CbGaD
Minocycline—SLC22A7—Fluorouracil—head and neck cancer	0.0986	0.567	CbGbCtD
Minocycline—SLC22A7—Docetaxel—head and neck cancer	0.0753	0.433	CbGbCtD
Minocycline—CASP3—cochlea—head and neck cancer	0.00887	0.11	CbGeAlD
Minocycline—IL1B—cartilage tissue—head and neck cancer	0.00461	0.0571	CbGeAlD
Minocycline—MMP9—cartilage tissue—head and neck cancer	0.00384	0.0476	CbGeAlD
Minocycline—CYCS—exocrine gland—head and neck cancer	0.00366	0.0453	CbGeAlD
Minocycline—Doxycycline—MMP8—head and neck cancer	0.00362	1	CrCbGaD
Minocycline—CASP3—tongue—head and neck cancer	0.00348	0.0432	CbGeAlD
Minocycline—CASP3—exocrine gland—head and neck cancer	0.00313	0.0388	CbGeAlD
Minocycline—CYCS—mouth—head and neck cancer	0.00274	0.0339	CbGeAlD
Minocycline—CASP3—mouth—head and neck cancer	0.00234	0.029	CbGeAlD
Minocycline—CYCS—neck—head and neck cancer	0.00234	0.029	CbGeAlD
Minocycline—CASP3—neck—head and neck cancer	0.002	0.0248	CbGeAlD
Minocycline—IL1B—mouth—head and neck cancer	0.00187	0.0232	CbGeAlD
Minocycline—CASP1—connective tissue—head and neck cancer	0.00174	0.0216	CbGeAlD
Minocycline—CYCS—connective tissue—head and neck cancer	0.00168	0.0208	CbGeAlD
Minocycline—CASP1—epithelium—head and neck cancer	0.00165	0.0205	CbGeAlD
Minocycline—CASP3—parotid gland—head and neck cancer	0.00163	0.0202	CbGeAlD
Minocycline—CYCS—epithelium—head and neck cancer	0.00159	0.0197	CbGeAlD
Minocycline—MMP9—mouth—head and neck cancer	0.00156	0.0193	CbGeAlD
Minocycline—CASP1—trachea—head and neck cancer	0.00146	0.0181	CbGeAlD
Minocycline—CASP3—connective tissue—head and neck cancer	0.00144	0.0178	CbGeAlD
Minocycline—CASP3—epithelium—head and neck cancer	0.00136	0.0169	CbGeAlD
Minocycline—MMP9—neck—head and neck cancer	0.00133	0.0165	CbGeAlD
Minocycline—CASP1—lymphoid tissue—head and neck cancer	0.00127	0.0158	CbGeAlD
Minocycline—CYCS—lymphoid tissue—head and neck cancer	0.00123	0.0152	CbGeAlD
Minocycline—CASP3—trachea—head and neck cancer	0.00121	0.0149	CbGeAlD
Minocycline—CASP1—thyroid gland—head and neck cancer	0.00116	0.0143	CbGeAlD
Minocycline—IL1B—connective tissue—head and neck cancer	0.00115	0.0142	CbGeAlD
Minocycline—CYCS—thyroid gland—head and neck cancer	0.00111	0.0138	CbGeAlD
Minocycline—IL1B—epithelium—head and neck cancer	0.00109	0.0135	CbGeAlD
Minocycline—CASP3—lymphoid tissue—head and neck cancer	0.00105	0.013	CbGeAlD
Minocycline—CASP1—head—head and neck cancer	0.00103	0.0127	CbGeAlD
Minocycline—CYCS—head—head and neck cancer	0.000988	0.0122	CbGeAlD
Minocycline—MMP9—connective tissue—head and neck cancer	0.000956	0.0118	CbGeAlD
Minocycline—CASP3—thyroid gland—head and neck cancer	0.000954	0.0118	CbGeAlD
Minocycline—VEGFA—trachea—head and neck cancer	0.000947	0.0117	CbGeAlD
Minocycline—MMP9—epithelium—head and neck cancer	0.000908	0.0112	CbGeAlD
Minocycline—CASP3—head—head and neck cancer	0.000846	0.0105	CbGeAlD
Minocycline—IL1B—lymphoid tissue—head and neck cancer	0.000839	0.0104	CbGeAlD
Minocycline—IL1B—thyroid gland—head and neck cancer	0.000762	0.00944	CbGeAlD
Minocycline—ALOX5—connective tissue—head and neck cancer	0.000756	0.00936	CbGeAlD
Minocycline—VEGFA—thyroid gland—head and neck cancer	0.000749	0.00928	CbGeAlD
Minocycline—CASP1—lymph node—head and neck cancer	0.000718	0.0089	CbGeAlD
Minocycline—MMP9—lymphoid tissue—head and neck cancer	0.000699	0.00866	CbGeAlD
Minocycline—CYCS—lymph node—head and neck cancer	0.000692	0.00857	CbGeAlD
Minocycline—IL1B—head—head and neck cancer	0.000676	0.00837	CbGeAlD
Minocycline—CASP3—lymph node—head and neck cancer	0.000592	0.00734	CbGeAlD
Minocycline—MMP9—head—head and neck cancer	0.000563	0.00698	CbGeAlD
Minocycline—ALOX5—lymphoid tissue—head and neck cancer	0.000553	0.00685	CbGeAlD
Minocycline—ALOX5—thyroid gland—head and neck cancer	0.000502	0.00622	CbGeAlD
Minocycline—IL1B—lymph node—head and neck cancer	0.000473	0.00586	CbGeAlD
Minocycline—VEGFA—lymph node—head and neck cancer	0.000465	0.00577	CbGeAlD
Minocycline—ALOX5—head—head and neck cancer	0.000445	0.00552	CbGeAlD
Minocycline—MMP9—lymph node—head and neck cancer	0.000394	0.00489	CbGeAlD
Minocycline—ALOX5—lymph node—head and neck cancer	0.000312	0.00386	CbGeAlD
Minocycline—SLC22A8—head—head and neck cancer	0.000301	0.00373	CbGeAlD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—AKT1—head and neck cancer	7.81e-05	0.000494	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—MAPK3—head and neck cancer	7.77e-05	0.000492	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—STAT3—head and neck cancer	7.76e-05	0.000491	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	7.75e-05	0.00049	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	7.69e-05	0.000486	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ATP7B—head and neck cancer	7.68e-05	0.000486	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—AKT1—head and neck cancer	7.65e-05	0.000484	CbGpPWpGaD
Minocycline—VEGFA—Integrins in angiogenesis—AKT1—head and neck cancer	7.65e-05	0.000484	CbGpPWpGaD
Minocycline—IL1B—Immune System—STAT6—head and neck cancer	7.64e-05	0.000484	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CASP8—head and neck cancer	7.63e-05	0.000483	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—AKT1—head and neck cancer	7.55e-05	0.000478	CbGpPWpGaD
Minocycline—CYCS—Metabolism—DPYD—head and neck cancer	7.55e-05	0.000478	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—MAPK1—head and neck cancer	7.52e-05	0.000476	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—EGFR—head and neck cancer	7.52e-05	0.000476	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—TP53—head and neck cancer	7.47e-05	0.000473	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—PIK3CA—head and neck cancer	7.47e-05	0.000472	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—AKT1—head and neck cancer	7.46e-05	0.000472	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—MAPK3—head and neck cancer	7.42e-05	0.00047	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—HRAS—head and neck cancer	7.42e-05	0.000469	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—MAPK3—head and neck cancer	7.41e-05	0.000469	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—MAPK1—head and neck cancer	7.39e-05	0.000468	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—EGFR—head and neck cancer	7.39e-05	0.000468	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	7.37e-05	0.000467	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	7.37e-05	0.000466	CbGpPWpGaD
Minocycline—VEGFA—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	7.37e-05	0.000466	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—head and neck cancer	7.31e-05	0.000463	CbGpPWpGaD
Minocycline—MMP9—EPH-Ephrin signaling—HRAS—head and neck cancer	7.25e-05	0.000458	CbGpPWpGaD
Minocycline—VEGFA—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—head and neck cancer	7.2e-05	0.000455	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—STAT3—head and neck cancer	7.18e-05	0.000454	CbGpPWpGaD
Minocycline—CYCS—Metabolism—YAP1—head and neck cancer	7.16e-05	0.000453	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—MAPK1—head and neck cancer	7.06e-05	0.000447	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—MAPK1—head and neck cancer	7.05e-05	0.000446	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—MAPK3—head and neck cancer	7.01e-05	0.000443	CbGpPWpGaD
Minocycline—MMP9—CXCR4-mediated signaling events—AKT1—head and neck cancer	7e-05	0.000443	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TP53—head and neck cancer	6.86e-05	0.000434	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—MAPK3—head and neck cancer	6.86e-05	0.000434	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	6.83e-05	0.000432	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—KISS1—head and neck cancer	6.83e-05	0.000432	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—PIK3CA—head and neck cancer	6.82e-05	0.000432	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—CDH1—head and neck cancer	6.75e-05	0.000427	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—MAPK1—head and neck cancer	6.67e-05	0.000422	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—BCL2—head and neck cancer	6.62e-05	0.000419	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	6.6e-05	0.000417	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	6.6e-05	0.000417	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—PTEN—head and neck cancer	6.57e-05	0.000415	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—AKT1—head and neck cancer	6.55e-05	0.000415	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—BCL2—head and neck cancer	6.55e-05	0.000414	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—MAPK1—head and neck cancer	6.52e-05	0.000413	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—EGFR—head and neck cancer	6.52e-05	0.000413	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL2—head and neck cancer	6.42e-05	0.000406	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	6.4e-05	0.000405	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TP53—head and neck cancer	6.32e-05	0.0004	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—HRAS—head and neck cancer	6.31e-05	0.000399	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	6.31e-05	0.000399	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—HRAS—head and neck cancer	6.29e-05	0.000398	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	6.27e-05	0.000397	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TP53—head and neck cancer	6.21e-05	0.000393	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	6.19e-05	0.000392	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—AKT1—head and neck cancer	6.18e-05	0.000391	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—PIK3CA—head and neck cancer	6.13e-05	0.000388	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—AKT1—head and neck cancer	6.1e-05	0.000386	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—TP53—head and neck cancer	5.92e-05	0.000375	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—STAT3—head and neck cancer	5.87e-05	0.000372	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—AKT1—head and neck cancer	5.79e-05	0.000366	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—PIK3CA—head and neck cancer	5.79e-05	0.000366	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—CCND1—head and neck cancer	5.69e-05	0.00036	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—HRAS—head and neck cancer	5.67e-05	0.000359	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	5.66e-05	0.000358	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—PIK3CA—head and neck cancer	5.66e-05	0.000358	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.63e-05	0.000356	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GRP—head and neck cancer	5.62e-05	0.000356	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—MAPK3—head and neck cancer	5.61e-05	0.000355	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.58e-05	0.000353	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—PTEN—head and neck cancer	5.49e-05	0.000347	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	5.47e-05	0.000346	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—STAT6—head and neck cancer	5.46e-05	0.000345	CbGpPWpGaD
Minocycline—CASP1—Immune System—BCL2L1—head and neck cancer	5.44e-05	0.000344	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—PTEN—head and neck cancer	5.42e-05	0.000343	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—STAT3—head and neck cancer	5.41e-05	0.000342	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	5.36e-05	0.000339	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	5.36e-05	0.000339	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—HRAS—head and neck cancer	5.35e-05	0.000339	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—MAPK1—head and neck cancer	5.34e-05	0.000338	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—EGFR—head and neck cancer	5.34e-05	0.000338	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—NAT2—head and neck cancer	5.3e-05	0.000336	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—AKT1—head and neck cancer	5.24e-05	0.000332	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—HRAS—head and neck cancer	5.24e-05	0.000331	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	5.23e-05	0.000331	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—IL2—head and neck cancer	5.17e-05	0.000327	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—MAPK3—head and neck cancer	5.16e-05	0.000327	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—AKT1—head and neck cancer	5.01e-05	0.000317	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—MAPK1—head and neck cancer	4.91e-05	0.000311	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—YAP1—head and neck cancer	4.83e-05	0.000306	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—KISS1—head and neck cancer	4.74e-05	0.0003	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—AKT1—head and neck cancer	4.73e-05	0.000299	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	4.67e-05	0.000295	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—DPYD—head and neck cancer	4.65e-05	0.000294	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—MAPK3—head and neck cancer	4.63e-05	0.000293	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—PIK3CA—head and neck cancer	4.63e-05	0.000293	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—AKT1—head and neck cancer	4.63e-05	0.000293	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—NOTCH1—head and neck cancer	4.55e-05	0.000288	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TP53—head and neck cancer	4.5e-05	0.000285	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—MAPK1—head and neck cancer	4.46e-05	0.000282	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—EGFR—head and neck cancer	4.46e-05	0.000282	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	4.44e-05	0.000281	CbGpPWpGaD
Minocycline—CASP1—Immune System—CASP8—head and neck cancer	4.44e-05	0.000281	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	4.44e-05	0.000281	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—YAP1—head and neck cancer	4.41e-05	0.000279	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—MAPK1—head and neck cancer	4.41e-05	0.000279	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—EGFR—head and neck cancer	4.41e-05	0.000279	CbGpPWpGaD
Minocycline—CASP1—Immune System—CDH1—head and neck cancer	4.39e-05	0.000278	CbGpPWpGaD
Minocycline—CYCS—Metabolism—TYMS—head and neck cancer	4.3e-05	0.000272	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—HRAS—head and neck cancer	4.29e-05	0.000271	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—PIK3CA—head and neck cancer	4.26e-05	0.00027	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GSTM1—head and neck cancer	4.25e-05	0.000269	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	4.16e-05	0.000263	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—KISS1—head and neck cancer	4.12e-05	0.00026	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GPX1—head and neck cancer	4.07e-05	0.000258	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CYP1A1—head and neck cancer	4.03e-05	0.000255	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	3.95e-05	0.00025	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—NOTCH1—head and neck cancer	3.95e-05	0.00025	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HRAS—head and neck cancer	3.95e-05	0.00025	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GRP—head and neck cancer	3.9e-05	0.000247	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—PIK3CA—head and neck cancer	3.87e-05	0.000245	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	3.86e-05	0.000244	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—PIK3CA—head and neck cancer	3.83e-05	0.000242	CbGpPWpGaD
Minocycline—CASP1—Immune System—BCL2—head and neck cancer	3.81e-05	0.000241	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	3.8e-05	0.000241	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—STAT6—head and neck cancer	3.79e-05	0.00024	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—AKT1—head and neck cancer	3.78e-05	0.000239	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—STAT3—head and neck cancer	3.77e-05	0.000239	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	3.73e-05	0.000236	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—VEGFA—head and neck cancer	3.73e-05	0.000236	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—MAPK3—head and neck cancer	3.6e-05	0.000228	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—HRAS—head and neck cancer	3.58e-05	0.000227	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—HRAS—head and neck cancer	3.54e-05	0.000224	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—MAPK3—head and neck cancer	3.52e-05	0.000223	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	3.43e-05	0.000217	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—MAPK1—head and neck cancer	3.43e-05	0.000217	CbGpPWpGaD
Minocycline—IL1B—Immune System—BCL2L1—head and neck cancer	3.4e-05	0.000215	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GRP—head and neck cancer	3.39e-05	0.000214	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL2—head and neck cancer	3.36e-05	0.000212	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—YAP1—head and neck cancer	3.35e-05	0.000212	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—MAPK1—head and neck cancer	3.35e-05	0.000212	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—EGFR—head and neck cancer	3.35e-05	0.000212	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.32e-05	0.00021	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—STAT6—head and neck cancer	3.29e-05	0.000208	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—AKT1—head and neck cancer	3.16e-05	0.0002	CbGpPWpGaD
Minocycline—CASP1—Immune System—PTEN—head and neck cancer	3.16e-05	0.0002	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.15e-05	0.000199	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—AKT1—head and neck cancer	3.13e-05	0.000198	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MAPK3—head and neck cancer	3.06e-05	0.000194	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—YAP1—head and neck cancer	2.91e-05	0.000184	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MAPK1—head and neck cancer	2.91e-05	0.000184	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—EGFR—head and neck cancer	2.91e-05	0.000184	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.89e-05	0.000183	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—TP53—head and neck cancer	2.88e-05	0.000182	CbGpPWpGaD
Minocycline—CASP1—Immune System—STAT3—head and neck cancer	2.82e-05	0.000179	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	2.8e-05	0.000177	CbGpPWpGaD
Minocycline—IL1B—Immune System—CASP8—head and neck cancer	2.78e-05	0.000176	CbGpPWpGaD
Minocycline—IL1B—Immune System—CDH1—head and neck cancer	2.74e-05	0.000174	CbGpPWpGaD
Minocycline—CASP1—Immune System—MAPK3—head and neck cancer	2.7e-05	0.000171	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—HRAS—head and neck cancer	2.69e-05	0.00017	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IL2—head and neck cancer	2.66e-05	0.000169	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—VEGFA—head and neck cancer	2.66e-05	0.000168	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—TYMS—head and neck cancer	2.65e-05	0.000168	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—STAT3—head and neck cancer	2.63e-05	0.000167	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GSTM1—head and neck cancer	2.62e-05	0.000166	CbGpPWpGaD
Minocycline—CASP1—Immune System—MAPK1—head and neck cancer	2.57e-05	0.000162	CbGpPWpGaD
Minocycline—CASP1—Immune System—EGFR—head and neck cancer	2.57e-05	0.000162	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MAPK3—head and neck cancer	2.52e-05	0.000159	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GPX1—head and neck cancer	2.51e-05	0.000159	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP1A1—head and neck cancer	2.48e-05	0.000157	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTGS2—head and neck cancer	2.4e-05	0.000152	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MAPK1—head and neck cancer	2.39e-05	0.000151	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—EGFR—head and neck cancer	2.39e-05	0.000151	CbGpPWpGaD
Minocycline—IL1B—Immune System—BCL2—head and neck cancer	2.38e-05	0.000151	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—HRAS—head and neck cancer	2.34e-05	0.000148	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—STAT3—head and neck cancer	2.29e-05	0.000145	CbGpPWpGaD
Minocycline—CASP1—Immune System—PIK3CA—head and neck cancer	2.23e-05	0.000141	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MAPK3—head and neck cancer	2.18e-05	0.000138	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NOTCH1—head and neck cancer	2.18e-05	0.000138	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—MAPK3—head and neck cancer	2.14e-05	0.000136	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL2—head and neck cancer	2.1e-05	0.000133	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTEN—head and neck cancer	2.09e-05	0.000132	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MAPK1—head and neck cancer	2.08e-05	0.000131	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—EGFR—head and neck cancer	2.08e-05	0.000131	CbGpPWpGaD
Minocycline—CASP1—Immune System—HRAS—head and neck cancer	2.06e-05	0.00013	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.04e-05	0.000129	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—MAPK1—head and neck cancer	2.04e-05	0.000129	CbGpPWpGaD
Minocycline—IL1B—Immune System—PTEN—head and neck cancer	1.97e-05	0.000125	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—HRAS—head and neck cancer	1.92e-05	0.000122	CbGpPWpGaD
Minocycline—CASP1—Immune System—AKT1—head and neck cancer	1.82e-05	0.000115	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PIK3CA—head and neck cancer	1.77e-05	0.000112	CbGpPWpGaD
Minocycline—IL1B—Immune System—STAT3—head and neck cancer	1.77e-05	0.000112	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—head and neck cancer	1.71e-05	0.000108	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—AKT1—head and neck cancer	1.7e-05	0.000107	CbGpPWpGaD
Minocycline—IL1B—Immune System—MAPK3—head and neck cancer	1.69e-05	0.000107	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—HRAS—head and neck cancer	1.67e-05	0.000106	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—HRAS—head and neck cancer	1.64e-05	0.000104	CbGpPWpGaD
Minocycline—IL1B—Immune System—MAPK1—head and neck cancer	1.61e-05	0.000102	CbGpPWpGaD
Minocycline—IL1B—Immune System—EGFR—head and neck cancer	1.6e-05	0.000102	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NOTCH1—head and neck cancer	1.51e-05	9.57e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL2—head and neck cancer	1.5e-05	9.48e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTGS2—head and neck cancer	1.48e-05	9.34e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PIK3CA—head and neck cancer	1.47e-05	9.33e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—AKT1—head and neck cancer	1.47e-05	9.32e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCND1—head and neck cancer	1.46e-05	9.24e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—AKT1—head and neck cancer	1.44e-05	9.14e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PTEN—head and neck cancer	1.41e-05	8.92e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—PIK3CA—head and neck cancer	1.39e-05	8.81e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOTCH1—head and neck cancer	1.31e-05	8.3e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—HRAS—head and neck cancer	1.29e-05	8.15e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTEN—head and neck cancer	1.29e-05	8.15e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—VEGFA—head and neck cancer	1.27e-05	8.06e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—STAT3—head and neck cancer	1.26e-05	7.98e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MAPK3—head and neck cancer	1.2e-05	7.62e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—AKT1—head and neck cancer	1.2e-05	7.62e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MAPK1—head and neck cancer	1.15e-05	7.25e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—EGFR—head and neck cancer	1.15e-05	7.25e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—AKT1—head and neck cancer	1.14e-05	7.2e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL2—head and neck cancer	1.04e-05	6.58e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCND1—head and neck cancer	1.01e-05	6.42e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PIK3CA—head and neck cancer	9.95e-06	6.29e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTEN—head and neck cancer	9.79e-06	6.19e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—head and neck cancer	9.62e-06	6.09e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HRAS—head and neck cancer	9.2e-06	5.82e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PIK3CA—head and neck cancer	9.09e-06	5.75e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL2—head and neck cancer	9.03e-06	5.71e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—VEGFA—head and neck cancer	8.84e-06	5.59e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCND1—head and neck cancer	8.8e-06	5.57e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—STAT3—head and neck cancer	8.76e-06	5.54e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTEN—head and neck cancer	8.5e-06	5.38e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MAPK3—head and neck cancer	8.36e-06	5.29e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AKT1—head and neck cancer	8.13e-06	5.14e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MAPK1—head and neck cancer	7.96e-06	5.04e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EGFR—head and neck cancer	7.96e-06	5.03e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—STAT3—head and neck cancer	7.6e-06	4.81e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AKT1—head and neck cancer	7.42e-06	4.7e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MAPK3—head and neck cancer	7.26e-06	4.59e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MAPK1—head and neck cancer	6.91e-06	4.37e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EGFR—head and neck cancer	6.91e-06	4.37e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PIK3CA—head and neck cancer	6.91e-06	4.37e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—head and neck cancer	6.68e-06	4.23e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HRAS—head and neck cancer	6.39e-06	4.04e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PIK3CA—head and neck cancer	6e-06	3.79e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—head and neck cancer	5.8e-06	3.67e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AKT1—head and neck cancer	5.64e-06	3.57e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HRAS—head and neck cancer	5.55e-06	3.51e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AKT1—head and neck cancer	4.9e-06	3.1e-05	CbGpPWpGaD
